Grifols
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!About GRFS
Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others.
CEOJose Ignacio Abia Buenache
CEOJose Ignacio Abia Buenache
Employees23,833
Employees23,833
HeadquartersBarcelona, Catalonia
HeadquartersBarcelona, Catalonia
Founded1909
Founded1909
Employees23,833
Employees23,833
GRFS Key Statistics
Market cap7.76B
Market cap7.76B
Price-Earnings ratio14.17
Price-Earnings ratio14.17
Dividend yield1.64%
Dividend yield1.64%
Average volume1.06M
Average volume1.06M
High today$8.80
High today$8.80
Low today$8.64
Low today$8.64
Open price$8.67
Open price$8.67
Volume278.42K
Volume278.42K
52 Week high$11.14
52 Week high$11.14
52 Week low$6.19
52 Week low$6.19
Stock Snapshot
As of today, Grifols(GRFS) shares are valued at $8.72. The company's market cap stands at 7.76B, with a P/E ratio of 14.17 and a dividend yield of 1.6%.
On 2025-11-14, Grifols(GRFS) stock traded between a low of $8.64 and a high of $8.80. Shares are currently priced at $8.72, which is +0.9% above the low and -1.0% below the high.
Grifols(GRFS) shares are trading with a volume of 278.42K, against a daily average of 1.06M.
During the past year, Grifols(GRFS) stock moved between $6.19 at its lowest and $11.14 at its peak.
During the past year, Grifols(GRFS) stock moved between $6.19 at its lowest and $11.14 at its peak.